L1CAM and breast carcinoma: Li and Galileo [44] found that soluble L1CAM (sL1), produced by proteolytic cleavage of membrane-bound L1CAM, acted as a chemoattractant for breast cancer cells in transmigration assays and this effect was neutralized using sL1 blocking antibodies.